| Dr Roy Frederick Davis, MD, PHD | |
|
3200 Providence Dr, Anchorage, AK 99508-4615 | |
| (907) 212-6020 | |
| (907) 212-3041 |
| Full Name | Dr Roy Frederick Davis |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 3200 Providence Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699047803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 3016 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roy Frederick Davis, MD, PHD Po Box 196276, Anchorage, AK 99519-6276 Ph: (907) 212-6522 | Dr Roy Frederick Davis, MD, PHD 3200 Providence Dr, Anchorage, AK 99508-4615 Ph: (907) 212-6020 |
News Archive
The fight against a number of significant infectious diseases in the Asia-Pacific region has been given a boost through a new research collaboration between the National Health and Medical Research Council in Australia and the Agency for Science, Technology and Research in Singapore.
Depomed, Inc. today announced that Janssen Pharmaceuticals, Inc., has licensed rights to Depomed's Acuform gastric retentive drug delivery technology.
In recognition of World Voice Day on April 16, Norman D. Hogikyan, M.D., professor of otolaryngology at the University of Michigan Medical School and director of the U-M Vocal Health Center, reminds us not only to think about vocal health, but the ways in which the human voice influences our lives and unites us.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in a Phase II clinical study of its third-generation camptothecin compound, AR-67, in patients with Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.
The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced yesterday.
› Verified 3 days ago
Elizabeth Mumford Galloway, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-562-2211 Fax: 509-479-0214 | |
Wendy Bailey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr, Suite A-351, Anchorage, AK 99508 Phone: 907-212-4824 Fax: 907-212-4831 | |
Jay D. Johnson, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3801 Lake Otis Pkwy Ste 200, Anchorage, AK 99508 Phone: 907-212-6900 | |
Dr. Stephen Scott Baker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2841 Debarr Rd, Bldg A, Suite 23, Anchorage, AK 99508 Phone: 907-677-1864 Fax: 907-868-5167 | |
Dr. Rachel Mauryce Kerford Lescher, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4320 Diplomacy Dr, Suite 2300, Anchorage, AK 99508 Phone: 907-729-1000 Fax: 907-729-5244 | |
Dr. James Monroe Nesbitt Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3200 Providence Dr, Administration Office, Anchorage, AK 99508 Phone: 907-261-5098 Fax: 907-743-2358 | |
Dr. Emily Margaret Reilly, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-4068 |